Gut microbiome in inflammatory bowel disease and other chronic immune-mediated inflammatory diseases

Inflammatory Intestinal Diseases

Volumn 2, Issue 2, 2017, Pages 116-123

  Bernstein, Charles N ^a   Forbes, Jessica D ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Public Health Agency of Canada   (Canada)

Author keywords

Animal models; Chronic immune mediated inflammatory diseases; Dysbiosis; Gut microbiome; Inflammatory bowel disease

Indexed keywords

ANTIBIOTIC AGENT; GAMMA INTERFERON; GLATIRAMER; HYDROXYCHLOROQUINE; INTERLEUKIN 13; METHOTREXATE; MINOCYCLINE; PLACEBO; TUMOR NECROSIS FACTOR; VITAMIN D;

ACTINOMYCES; AKKERMANSIA; ANAEROSTIPES; B LYMPHOCYTE; BACTEROIDES; CD4+ T LYMPHOCYTE; CHRONIC IMMUNE MEDIATED INFLAMMATORY DISEASE; CLOSTRIDIA; COLLINSELLA; COPROCOCCUS; CROHN DISEASE; DESULFOVIBRIONACEAE; DISEASE SEVERITY; EGGERTHELLA; ENVIRONMENTAL FACTOR; EURYARCHAEOTA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FAECALIBACTERIUM PRAUSNITZII; FECALIBACTERIUM; FIRMICUTES; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; INTESTINAL IMMUNE RESPONSE; INTESTINE FLORA; LACHNOSPIRACEAE; LACTOBACILLUS; MEDICAL INFORMATION; MICROBIAL DIVERSITY; MULTIPLE SCLEROSIS; NONHUMAN; PREVOTELLA; PRIORITY JOURNAL; PSEUDOBUTYRIVIBRIO; PSORIASIS; PSORIATIC ARTHRITIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; RUMINOCOCCACEAE; RUMINOCOCCUS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SPECIES COMPOSITION; SPECIES RICHNESS; STREPTOCOCCUS; T LYMPHOCYTE; TH17 CELL; TH2 CELL; ULCERATIVE COLITIS;

EID: 85058711687     PISSN: 22969403     EISSN: 22969365     Source Type: Journal    
DOI: 10.1159/000481401     Document Type: Review

References (50)

1. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638
2. Swidsinski A, Loening-baucke V, Lochs H, Hale LP. Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol 2005; 11: 1131-1140
3. Forbes JD, Van Domselaar G, Bernstein CN. The gut microbiota in immune-mediated inflammatory diseases. Front Microbiol 2016; 7: 1081
4. Qin J, Li R, Raes J, Arumugam M, Burgdorf S, Manichanh C, Nielsen T, Pons N, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto J, Hansen T, Paslier D Le, Linneberg A, Nielsen HB, Pelletier E, Renault P, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H: A human gut microbial gene catalog established by metagenomic sequencing. Nature 2010; 464: 59-65
5. Forbes JD, Van Domselaar G, Bernstein CN. Microbiome survey of the inflamed and noninflamed gut at different compartments within the gastrointestinal tract of inflammatory bowel disease patients. Inflamm Bowel Dis 2016; 22: 817-825
6. Sekirov I, Russell S, Antunes L. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904
7. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4: 478-485
8. Noverr MC, Noggle RM, Toews GB, Huffnagle GB. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun 2004; 72: 4996-5003
9. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107-118
10. Ivanov II, Frutos R de L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008; 4: 337-349
11. Christensen HR, Pestka JJ, Alerts E. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2017; 168: 171-178
12. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005; 129: 827-836
13. Parkes M, Cortes A, van Heel DA, Brown MA. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet 2013; 14: 661-673
14. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Treuren W Van, Knight R, Bell JT, Spector TD, Clark AG, Ley RE. Human genetics shape the gut microbiome. Cell 2014; 159: 789-799
15. Sinha S, Boyden AW, Itani FR, Crawford MP, Karandikar NJ. CD8+ T-cells as immune regulators of multiple sclerosis. Front Immunol 2015; 6: 619
16. Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E. The gut microbiome in human neurological disease: a review. Ann Neurol 2017; 81: 369-382
17. Mahony SMO, Marchesi JR, Scully P, Codling C, Ceolho A, Quigley EMM, Cryan JF, Dinan TG. Microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 2009; 65: 263-267
18. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009; 136: 2003-2014
19. Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest 2015; 125: 926-938
20. Ochoa-Reparaz J, Mielcarz DW, Ditrio LE, Burroughs AR, Foureau DM, Haque-Begum S, Kasper LH. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 2009; 183: 6041-6050
21. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479: 538-541
22. Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, Chihara N, Tomita A, Sato W, Kim SW, Morita H, Hattori M, Yamamura T. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS One 2015; 10: 1-16
23. Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL, Cook S, Tankou S, Stuart F, Melo K, Nejad P, Smith K, Topcuolu BD, Holden J, Kivisakk P, Chitnis T, De Jager PL, Quintana FJ, Gerber GK, Bry L, Weiner HL. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 2016; 7: 12015
24. Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Soldan MMP, Luckey DH, Marietta E V, Jeraldo PR, Chen X, Weinshenker BG, Rodriguez M, Kantarci OH, Nelson H, Murray JA, Mangalam AK. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 2016; 6: 28484
25. Tremlett H, Fadrosh D, Lynch S, Hart K, Graves J, Lulu S, Aaen G, Belman A, Benson L, Casper C, Chitnis T, Gorman M, Krupp L, Lotze T, Ness J, Roalst S, Weinstock-Guttman B, Waubant E. Gut microbiome in early pediatric multiple sclerosis: a case-control study (P4.027). Neurology 2015; 84
26. Castillo Alvarez F, Perez Matute P, Colina Lizuain S. Intestinal microbiota in multiple sclerosis: influence of treatment with interferon β-1b. https://onlinelibrary.ectrims-congress. eu/ectrims/2016/32nd/146290/federico.castillo. lvarez.intestinal.microbiota.in.multiple. sclerosis.influence.html?f=m3
27. Bang C, Weidenbach K, Gutsmann T, Heine H, Schmitz RA. The intestinal archaea Methanosphaera stadtmanae and Methanobrevibacter smithii activate human dendritic cells. PLoS One 2014; 9: e99411
28. Cekanaviciute E, Debelius J, Singh S, Runia T, Nelson C, Yoo B, Kanner R, Crabtree-Hartman E, Mazmanian S, Knight R, Katz Sand I, Casaccia P, Cree B, Baranzini S. Gut dysbiosis is a feature of MS and it is characterized by bacteria able to regulate lymphocyte differentiation in vitro. Mult Scler J 2016; 22: 58-59
29. Png CW, Linden SK, Gilshenan KS, Zoetendal EG, Mcsweeney CS, Sly LI, McGuckin MA, Florin THJ. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 2010; 105: 2420-2428
30. Tremlett H, Fadrosh DW, Faruqi AA, Zhu F, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, Aaen G, Belman A, Benson L, Charles Casper T, Chitnis T, Gorman M, Harris Y, Krupp L, Lotze TE, Ness J, Olsen C, Rodriguez M, Rose J, Simmons TC, Tillema JM, Weinstock-Guttman B. Gut microbiota in early pediatric multiple sclerosis: a case control study. Eur J Neurol 2016; 23: 1308-1321
31. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Spencer CM, Lynch SV, Zamvil SS, Waubant E, US Network of Pediatric MS Centers: Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls. BMC Neurol 2016; 16: 182
32. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Lynch S, Waubant E. Gut microbiota composition and relapse risk in pediatric MS: a pilot study. J Neurol Sci 2016; 363: 153-157
33. Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, Venkatesan A, Fraser CM, Mowry EM. Gut microbiota in multiple sclerosis. J Investig Med 2015; 63: 729-734
34. Kohashi O, Kuwata J, Umehara K, Uemura F, Takahashi T, Ozawa A. Susceptibility to adjuvant-induced arthritis among germfree, specific-pathogen-free, and conventional rats. Infect Immun 1979; 26: 791-794
35. O'Dell JR, Haire CE, Palmer W, Drymalski W, Wees S, Blakely K, Churchill M, Eckhoff PJ, Weaver A, Doud D, Erikson N, Dietz F, Olson R, Maloley P, Klassen LW, Moore GF. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1997; 40: 842-848
36. Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV, Murray J, Nelson H, Matteson EL, Taneja V. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med 2016; 8: 43
37. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux J-J, Blugeon S, Bridonneau C, Furet J-P, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottiere HM, Dore J, Marteau P, Seksik P, Langella P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105: 16731-16736
38. Kugathasan S, Denson LA, Walters TD, Kim M-O, Marigorta U, Schirmer M, Mondal K, Liu C, Griffiths AM, Noe JD, Crandall WV, Snapper SB, Rabizadeh S, Rosh JR, Shapiro JM, Guthery S, Mack DR, Kellermayer R, Kappelman M, Steiner S, Moulton DE, Keljo DJ, Cohen S, Oliva-Hemker M, Heyman MB. Early anti-TNF is effective in preventing internal penetrating but not stricturing disease complications in children newly diagnosed with Crohn?s disease: a prospective risk prediction model for disease behavior study. Gastroenterology 2017; 152: S64
39. Presley LL, Wei B, Braun J, Borneman J. Bacteria associated with immunoregulatory cells in mice. Appl Environ Microbiol 2010; 76: 936-941
40. Jones-hall YL, Kozik A, Nakatsu C. Ablation of tumor necrosis factor is associated with decreased inflammation and alterations of the microbiota in a mouse model of inflammatory bowel disease. PLoS One 2015; 10: e0119441
41. Bosshard PP, Zbinden R, Altwegg M. Turicibacter sanguinis gen. nov., sp. nov., a novel anaerobic, Gram-positive bacterium. Int J Syst Evol Microbiol 2002; 52: 1263-1266
42. Scher J, Sczesnak A, Longman R, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer E, Abramson S, Huttenhower C, Littman D. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013; 2: e01202
43. Liu X, Zou Q, Zeng B, Fang Y, Wei H. Analysis of fecal lactobacillus community structure in patients with early rheumatoid arthritis. Curr Microbiol 2013; 67: 170-176
44. Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, Wu X, Li J, Tang L, Li Y, Lan Z, Chen B, Li Y, Zhong H, Xie H, Jie Z, Chen W, Tang S, Xu X, Wang X, Cai X, Liu S, Xia Y, Li J, Qiao X, Al-Aama JY, Chen H, Wang L, Wu Q, Zhang F, Zheng W, Li Y, Zhang M, Luo G, Xue W, Xiao L, Li J, Chen W, Xu X, Yin Y, Yang H, Wang J, Kristiansen K, Liu L, Li T, Huang Q, Li Y, Wang J. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 2015; 21: 895-905
45. Wang W, Chen L, Zhou R, Wang X, Song L, Huang S, Wang G, Xia B. Increased proportions of bifidobacterium and the lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel. J Clin Microbiol 2014; 52: 398-406
46. Bernstein CN. Treatment of IBD: where we are and where we are going. Am J Gastroenterol 2015; 110: 114-126
47. Yan D, Issa N, Afifi L, Jeon C, Chang H, Liao W. The role of the skin and gut microbiome in psoriatic disease. Curr Derm Rep 2017; 6: 94-103
48. Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, Marmon S, Neimann A, Brusca S, Patel T, Manasson J, Pamer EG, Littman DR, Abramson SB. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 2015; 67: 128-139
49. Masallat D, Moemen D, State A. Gut bacterial microbiota in psoriasis: a case control study. African J Microbiol Res 2016; 10: 1337-1343
50. Eppinga H, Weiland CJS, Bing Thio H, van Der Woude CJ, Nijsten TEC, Peppelenbosch MP, Konstantinov SR. Similar depletion of protective Faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in Hidradenitis suppurativa . J Crohns Colitis 2016; 10: 1067-1075